Gabelli Funds Portfolio Manager Jeff Jonas in CNBC Pro

Viking stock doubled Tuesday. Here’s where the next moves in the obesity space could come from

Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but given the vast and valuable market, rivals are still eager to join the race.

Read more here: